Form 4: UNH Director Acquires Deferred Stock Units
Insider Transaction Report
UnitedHealth Group Director Valerie C. Montgomery Rice M.D. acquired 270 deferred stock units as part of her regular quarterly compensation.
Summary
- Valerie C. Montgomery Rice M.D., a Director of UnitedHealth Group Inc. (UNH), reported an acquisition of securities.
- The transaction occurred on October 1, 2025, involving the acquisition of 270 shares of Common Stock.
- These shares were acquired at a price of $0, indicating a grant rather than a purchase.
- The acquisition represents deferred stock units granted as regular quarterly compensation for her service as a director.
- The deferred stock units are immediately vested but must be retained by the director until the completion of her service on the Board.
- Following this transaction, Valerie C. Montgomery Rice M.D. beneficially owns 6,897 shares of Common Stock.
Sentiment
Score: 7
Explanation: The acquisition of deferred stock units by a director as part of regular compensation is a routine event that aligns management interests with shareholders, reflecting standard corporate governance practices. This is generally viewed positively for governance and alignment, but is not a significant market-moving event.
Positives
- Director Valerie C. Montgomery Rice M.D. received 270 deferred stock units as part of her regular quarterly compensation, reflecting standard governance practices.
- The deferred stock units are immediately vested, providing the director with immediate ownership rights.
- The requirement to retain these units until the director's completion of service on the Board aligns the director's long-term interests with those of shareholders.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation Policy | Grant of 270 deferred stock units as regular quarterly compensation for director service. These units are immediately vested but must be retained by the director until the completion of their service on the Board. | 10/01/2025 | This policy aligns the director's long-term financial interests with the company's performance and shareholder value by mandating equity retention throughout their board tenure. |
Related Party Transactions
- Acquisition of 270 deferred stock units by Director Valerie C. Montgomery Rice M.D. from UnitedHealth Group Inc. as regular quarterly compensation.
Stakeholder Impact
- Shareholders: The equity grant aligns the director's financial interests with shareholder value, potentially fostering more long-term strategic decisions.
- Directors: Provides compensation for board service and incentivizes continued commitment to the company's long-term success.
Next Steps
- Director Valerie C. Montgomery Rice M.D. is required to retain the deferred stock units until the completion of her service on the UnitedHealth Group Board.
Key Dates
| Date | Description |
|---|---|
| 10/01/2025 | Date of earliest transaction, involving the acquisition of deferred stock units. |
| 10/03/2025 | Signature date of the reporting person's attorney-in-fact for the filing. |
Recommendation
holdThis Form 4 reports a routine grant of deferred stock units to a director as part of regular compensation. While it indicates alignment of interests, it does not provide new material information about the company's operational or financial performance that would alter an investment thesis. Therefore, a 'hold' recommendation is appropriate based solely on this filing.
Keywords
UNH, UnitedHealth Group, Form 4, Insider Transaction, Director Compensation, Deferred Stock Units, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.